Overview of Licensed Product. During the Initial Development Period, and in accordance with the terms and conditions of this Agreement, the Parties will collaborate to Develop the Licensed Product in accordance with the Development Plan for such Licensed Product, including where applicable, conducting any necessary Research in order to submit the applicable Regulatory Filings to enable FPFD of the first Phase 1 Study for such Licensed Product. NVS will thereafter have the sole right, subject to Section 6.1(d) and Article 9, to conduct and be responsible for conducting, at its cost and expense, further Research, Development and Commercialization of such Licensed Product.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Pliant Therapeutics, Inc.), Collaboration and License Agreement (Pliant Therapeutics, Inc.)